020 7713 0990

The objective of this guideline is to provide healthcare professionals with pragmatic guidance on the management of patients with FVIII/FIX inhibitors although individual patient circumstances may dictate an alternative approach.

Declaration of Interests

The BSH paid the expenses incurred during the writing of this guidance. None of the authors had conflicts of interest to declare. All authors have made a declaration of interests to the BSH and Task Force Chairs which may be viewed on request.